Cargando…

Ceftriaxone/hydroxychloroquine/tocilizumab: QT prolongation, torsade-de-pointes and off label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726269/ http://dx.doi.org/10.1007/s40278-020-86934-8

Ejemplares similares

Hydroxychloroquine: Torsades de pointes following off label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: QTc interval prolongation and torsades de pointes following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine/lopinavir/ritonavir: Complete atrioventricular-block, torsades-de-pointes and QT-interval-prolongation following off label use: 2 case reports
Publicado: (2020)

DOTHIEPIN, QT PROLONGATION AND TORSADES DE POINTES
por: Andrade, Chittaranjan, et al.
Publicado: (1999)

Azithromycin/hydroxychloroquine: Torsade-de-pointes following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Torsades-de-pointes following off label treatment: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Torsades de pointes following off-label use: case report
Publicado: (2021)

Hydroxychloroquine: QT prolongation due to off-label use: case report
Publicado: (2022)

Chloroquine/erythromycin: QT interval prolongation and Torsade de Pointes: case report
Publicado: (2020)

Hydroxychloroquine/remdesivir/tocilizumab: Increase in corrected QT interval and off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine/tocilizumab: QTc prolongation and off label use: case report
Publicado: (2020)

Hydroxychloroquine: Prolonged QT interval following off label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QT prolongation following off label use: case report
Publicado: (2022)

Hydroxychloroquine: QT interval prolongation following off-label use: case report
Publicado: (2022)

QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin
por: Chorin, Ehud, et al.
Publicado: (2020)

Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine
por: Sarayani, Amir, et al.
Publicado: (2021)

QT prolongation and torsades de pointes with psychotropic agents
por: Desai, Nagaraj, et al.
Publicado: (2015)

Azithromycin/hydroxychloroquine: Prolonged QT interval during off label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Prolonged corrected QT following off label use: case report.
Publicado: (2020)

Multiple drugs: QTc prolongation leading to torsades-de-pointes and off-label use: case report
Publicado: (2021)

Ceftriaxone/heparin/hydroxychloroquine: Thrombocytopenia and off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine interaction: QT interval prolongation following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Corrected QT-interval prolongation following off label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QT prolongation and ventricular extrasystole secondary to off label use: case report
Publicado: (2021)

Hydroxychloroquine: Electrical storm and QT interval prolongation following off-label use: case report
Publicado: (2020)

QT Prolongation Complicated with Torsades de Pointes in Prosthetic Mitral Valve Endocarditis: A Case Report
por: Tounsi, A., et al.
Publicado: (2012)

Ceftriaxone/hydroxychloroquine/lopinavir: Lack of efficacy in off-label use: case report
Publicado: (2021)

Caspofungin/ceftriaxone/hydroxychloroquine: Brugada syndrome and off-label use: case report
Publicado: (2021)

QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine
por: Malone, Katie, et al.
Publicado: (2020)

Azithromycin/hydroxychloroquine: QT prolongation with a notched broad T-wave following off-label therapy: case report
Publicado: (2020)

Ceftriaxone/cobicistat/darunavir/hydroxychloroquine: Off-label use and lack of efficacy: case report
Publicado: (2022)

A Case of Hypoglycemiainduced QT Prolongation Leading to Torsade de Pointes and a Review of Pathophysiological Mechanisms
por: Hannoodi, Faris, et al.
Publicado: (2017)

Torsades de Pointes associated with QT prolongation after catheter ablation of paroxysmal atrial fibrillation
por: Park, Yae Min, et al.
Publicado: (2017)

Recurrent takotsubo with prolonged QT and torsade de pointes and left ventricular thrombus
por: Ahmed, Alaa Eldin K., et al.
Publicado: (2017)

QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review
por: Jankelson, Lior, et al.
Publicado: (2020)

Azithromycin/hydroxychloroquine: Torsade de pointes, premature atrial contraction and right bundle branch block following off-label use: 4 case reports
Publicado: (2021)

QT interval prolongation and torsade de pointes: Synergistic effect of flecainide and H(1) receptor antagonists
por: Acosta-Materán, Carlos, et al.
Publicado: (2016)

His Bundle Pacing in Amiodarone-Induced Complete Heart Block, QT Prolongation, and Torsade de Pointes
por: Tan, Vern Hsen, et al.
Publicado: (2020)

Torsade de Pointes Due to QT Prolongation after Pulmonary Vein Isolation for Persistent Atrial Fibrillation
por: Chikata, Akio, et al.
Publicado: (2021)

Azithromycin/hydroxychloroquine: Prolongation of the QT interval: case report
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_799bbb6pj88n4gt1uvekk031a2